The effect of age and weight on vancomycin serum trough concentrations in pediatric patients. - Wikidata - awgldk - TriplyDB

The effect of age and weight on vancomycin serum trough concentrations in pediatric patients.

The effect of age and weight on vancomycin serum trough concentrations in pediatric patients.

http://www.wikidata.org/entity/Q37347361

about

Pediatric Obesity: Pharmacokinetic Alterations and Effects on Antimicrobial Dosing.Population Pharmacokinetic Assessment and Pharmacodynamic Implications of Pediatric Cefepime Dosing for Susceptible-Dose-Dependent Organisms Pediatric Assessment of Vancomycin Empiric Dosing (PAVED): a Retrospective Review.Determining the optimal vancomycin daily dose for pediatrics: a meta-analysis.Balancing vancomycin efficacy and nephrotoxicity: should we be aiming for trough or AUC/MIC?Vancomycin: over 50 years later and still a work in progress.Use of Individual Pharmacokinetics to Improve Time to Therapeutic Vancomycin Trough in Pediatric Oncology Patients.

P2860

Q36247129-89B132A2-8780-4CC5-BB84-2AE17A1338F3 Q36730158-0E3590DF-6DFD-4A72-8221-066B94B48C35 Q38392526-C2104068-6A8A-4B74-B713-8A80BB7F2154 Q38641774-A00813F7-A01D-4FE0-8AAD-29CC56E7E8EC Q39044128-A36C77E0-656C-4F1F-83EF-6262BF7D2274 Q43658014-4935D268-38BD-4009-A7BF-4F9417EE54B5 Q55136102-0D31C7FD-5D1B-464F-B955-B1293BE143DF

P2860

The effect of age and weight on vancomycin serum trough concentrations in pediatric patients.

http://www.wikidata.org/entity/Q37347361

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The effect of age and weight o ...... rations in pediatric patients.

@en

The effect of age and weight o ...... rations in pediatric patients.

@nl

type

label

The effect of age and weight o ...... rations in pediatric patients.

@en

The effect of age and weight o ...... rations in pediatric patients.

@nl

prefLabel

The effect of age and weight o ...... rations in pediatric patients.

@en

The effect of age and weight o ...... rations in pediatric patients.

@nl

P1433

Q37347361-C41A690F-4B4C-408A-A23D-F51F350192CC

P1476

Q37347361-3697A264-BD9F-442F-89FF-F2733C33E737

P2093

Q37347361-1954E2EF-7BC2-41ED-A34E-539EC97022A2

Q37347361-2C55C320-2CCB-4218-BC23-59D98BC01DE6

Q37347361-68E4C2AA-7C65-442F-A1EE-19D93C56FCEA

Q37347361-FF276366-C74C-44A8-9197-8B601026BD80

P2860

Q37347361-0156BD0E-2A26-4903-B6A2-F6C085A70378

Q37347361-175C6B94-327D-4F09-AEE0-E274E229429D

Q37347361-18F5F5F8-2376-44FB-BCD1-2AA8370DD8B6

Q37347361-1CB17DA8-7325-467C-AC3B-F9531E4B1318

Q37347361-22F1FCA9-A76B-4798-B9C5-8069C7F72DF0

Q37347361-23545976-D304-4314-BA29-319DFBB6FE29

Q37347361-264C42F6-C245-4DC9-A776-88C4D29472BF

Q37347361-4496D8CB-A6BE-465C-BCD1-7116E50BF4A7

Q37347361-4F62D06F-D5EF-44E5-85BD-967124C81110

Q37347361-4FB6CDF7-10BF-4925-AA77-2D5C398EE1B8

P304

Q37347361-608992F7-9E41-4FBF-93D5-58F8CC352E19

P31

Q37347361-7EE8054A-654D-4C5F-AE03-C89AB5D86750

P356

Q37347361-0400A87F-AB6C-4766-AF5F-FFC4BB3D70A0

P407

Q37347361-0359EAFF-2A96-4FC9-898B-BC61DE7DA8AD

P433

Q37347361-D84C550C-EFD5-4690-8379-C0ED00A70B70

P478

Q37347361-D0F6D681-600A-41F0-9095-289927584A95

P577

Q37347361-46A2CEA4-2D08-4297-9474-11B200A409D1

P698

Q37347361-4227BDAD-DD86-4D3D-A617-A3BD49109FD0

P932

Q37347361-58022ACC-D593-497E-B17F-DEE214EEBEAE

P356

P1433

Pharmacotherapy

P1476

The effect of age and weight o ...... rations in pediatric patients.

@en

P2093

Kevin K Graner

http://www.w3.org/2001/XMLSchema#string

Ritu Banerjee

http://www.w3.org/2001/XMLSchema#string

Ronald M Sieve

http://www.w3.org/2001/XMLSchema#string

Theresa Madigan

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.

Therapeutic monitoring of vancomycin according to initial dosing regimen in pediatric patients.

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: a Monte Carlo simulation

Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate.

An evaluation of initial vancomycin dosing in infants, children, and adolescents.

Vancomycin pharmacokinetics in normal and morbidly obese subjects

Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique.

Integrated population pharmacokinetic analysis of voriconazole in children, adolescents, and adults.

P304

1264-1272

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PHAR.1331

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23864541

http://www.w3.org/2001/XMLSchema#string

P932

3842376

http://www.w3.org/2001/XMLSchema#string